ACADEMIC STAFF

Leong Sai Mun2b

Contact Information

Email
patlsm@nus.edu.sg

Telephone
+65 6772 4703

Research Themes

  • CANCER BIOLOGY

Other Information

ORCID

http://orcid.org/0000-0002-2236-4492

Social Media

Leong Sai Mun

ASSISTANT PROFESSOR (RESEARCH), YONG LOO LIN SCHOOL OF MEDICINE, NUS
PRIMARY MEMBER, NUS CENTRE FOR CANCER RESEARCH (N2CR)

RESEARCH FOCUS

    • Unraveling the intricacies of cancer sociobiology: Investigating the influence of social relationships among cancer cells on tumor processes and therapy resistance.
    • Elucidating the role of giant cells known as Poly Aneuploid Cancer Cells (PACCs) in therapy resistance.

BIOGRAPHY

Dr Leong Sai Mun obtained a First Class Honours in Biology and subsequently, a Doctor of Philosophy from the National University of Singapore (NUS). He subsequently performed his postdoctoral fellow in molecular neurology (focusing on apoptotic cell death in Parkinson’s disease) in Department of Biological Science, NUS, and then in molecular oncology (focusing on the biology of circulating tumour cells) in National University Hospital (Singapore).

Currently, as a Research Assistant Professor in the Department of Pathology at the National University of Singapore and a member of the NUS Centre for Cancer Research (N2CR), Dr Leong brings forth an extensive academic background in life sciences, encompassing diverse disciplines such as evolutionary biology, natural sciences, and advanced cell and molecular techniques.

In recent times, he has showcased his adaptability by broadening his research horizons into the dynamic domains of game theory and sociobiology. This interdisciplinary approach has empowered him and his team to explore innovative perspectives in comprehending the complex social behaviours exhibited by cancer cells. Presently, his primary focus revolves around investigating how these social dynamics impact crucial cancer processes, particularly the response to chemotherapeutic treatments.

Recent Publications

  • Dynamic altruistic cooperation within breast tumors.
    Masroni MSB, et al. Mol. Cancer. 22, 206 (2023)
    https://doi.org/10.1186/s12943-023-01896-7
    ♦ As Senior / Corresponding Author
    ♦ Featured in:
    • Channel News Asia (Top Story)
    • Channel 5 News (Top Story)
    • Suria News (Top Story)
    • Channel 8 News
    • Channel U
    • Straits Times
    • Lianhe Zaobao
    • Capital 958 News
    • 8world
    • Berita Mediacorp
    • >30 other local or international online media sites
  • miR-101-5p modulation of CD47 in diffuse large B-cell lymphoma: Implications for anti-CD47 immunotherapy and prognostication
    ♦ Masroni MSB, et al. Br J Haematol. Dec 12. (2023)
    https://doi.org/10.1111/bjh.19264
    ♦ As Co-First Author
  • MicroRNA Landscape in Endometrial Carcinomas in an Asian population: Unraveling Subtype-Specific Signatures.
    ♦ Tan GZL, et al. Cancers. 15(21), 526. (2023)
    https://doi.org/10.3390/cancers15215260
    ♦ As Co-Author
  • MicroRNAs as Potential Biomarkers in the Differential Diagnosis of Lipomatous Tumors and Their Mimics.
    ♦ Tan HM, et al. Int. J. Mol. Sci. 23(14), 780. (2023)
    https://doi.org/10.3390/ijms23147804
    ♦ As Co-Author
  • ETC-159, an Upstream Wnt inhibitor, Induces Tumour Necrosis via Modulation of Angiogenesis in Osteosarcoma.
    ♦ Chua K, et al. Int. J. Mol. Sci. 24(5), 475. (2023)
    https://doi.org/10.3390/ijms24054759
    ♦ As Co-Author

Group Members

    • MUHAMMAD SUFYAN BIN MASRONI
    • POON KOK SIONG
    • PANG CHU SUEN
    • LU JING XUAN
    • SYBIL LIM SHI EN
    • NICOLE HENG ZI YI
Scroll to Top